Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles:: A novel class of cyclooxygenase-2 inhibitors

被引:85
作者
Gadad, Andanappa K. [1 ,2 ]
Palkar, Mahesh B. [2 ]
Arland, K. [2 ]
Noolvi, Malleshappa N. [2 ]
Boreddy, Thippeswamy S. [3 ]
Wagwade, J. [3 ]
机构
[1] Univ W Indies, Fac Med Sci, Sch Pharm, Trinidad Tobago, WI USA
[2] JN Med Coll, Dept Med Chem, Belgaum 590010, Karnataka, India
[3] JN Med Coll, Coll Pharm, Belgaum 590010, Karnataka, India
关键词
D O I
10.1016/j.bmc.2007.09.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A series of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives 15a-j have been synthesized by the reaction of 2-amino-5-trifluoromethyl/sulfonamido-1,3,4-thiadiazoles 14a-b and appropriately substituted alpha-bromo-1,2-(p-substituted)diaryl-l-ethanones 13a-h. Structures of these compounds were established by IR, H-1 NMR, C-13 NMR, Mass, and HRMS data. The selected compounds were evaluated for their preliminary in vitro cyclooxygenase inhibitory activity against COX-2 and COX-lenzymes using colorimetric method. The compounds tested showed selective inhibitory activity toward COX-2 (80.6-49.4%) over COX-1 (30.6-8.6), amongst them compounds 15f and 15j showed appreciable COX-2 selective inhibitory activity. These compounds also exhibited significant anti-inflammatory activity (70.09-42.32%), which is comparable to that of celecoxib in the carrageenan-induced rat paw edema method. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 33 条
[1]
CEREBROVASODILATATION THROUGH SELECTIVE-INHIBITION OF THE ENZYME CARBONIC-ANHYDRASE .2. IMIDAZO[2,1-B]THIADIAZOLE AND IMIDAZO[2,1-B]THIAZOLESULFONAMIDES [J].
BARNISH, IT ;
CROSS, PE ;
DICKINSON, RP ;
GADSBY, B ;
PARRY, MJ ;
RANDALL, MJ ;
SINCLAIR, IW .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (02) :117-121
[2]
5,6-DIARYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLES - A NEW CLASS OF IMMUNOREGULATORY ANTIINFLAMMATORY AGENTS [J].
BENDER, PE ;
HILL, DT ;
OFFEN, PH ;
RAZGAITIS, K ;
LAVANCHY, P ;
STRINGER, OD ;
SUTTON, BM ;
GRISWOLD, DE ;
DIMARTINO, M ;
WALZ, DT ;
LANTOS, I ;
LADD, CB .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (09) :1169-1177
[3]
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[4]
COCHRAN FR, 1996, EXPERT OPIN INV DRUG, V5, P449
[5]
STERIC AND ELECTRONIC EFFECTS CONTROLLING THE SYNTHESIS OF BRIDGEHEAD NITROGEN-HETEROCYCLES [J].
DESTEVENS, G ;
EAGER, M ;
TARBY, C .
HETEROCYCLES, 1993, 35 (02) :763-773
[6]
Fink C A, 2003, BURGERS MED CHEM DRU, V3, P65
[7]
NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[8]
Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives [J].
Gadad, AK ;
Noolvi, MN ;
Karpoormath, RV .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (21) :5651-5659
[9]
Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives [J].
Gadad, AK ;
Mahajanshetti, CS ;
Nimbalkar, S ;
Raichurkar, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (09) :853-857
[10]
GANS KR, 1990, J PHARMACOL EXP THER, V254, P180